Despite their clinical differences, these disorders share key pathological hallmarks, such as the accumulation and aggregation of disease-specific proteins, for example tau (MAPT) in AD and other tauopathies and α-synuclein (SNCA) in PD and other synucleinopathies [19,20]. The gene discussed is MAPT; the disease is synucleinopathy.